The Fate of Circulating Walker 256 Tumour Cells Injected Intravenously in Rats
1963

The Fate of Circulating Walker 256 Tumour Cells in Rats

Sample size: 100 publication Evidence: moderate

Author Information

Author(s): J. D. Griffiths, A. J. Salsbury

Primary Institution: St. Bartholomew's Hospital, London

Hypothesis

What happens to circulating Walker 256 tumour cells after they are injected into rats?

Conclusion

Circulating Walker 256 tumour cells initially adhere to pulmonary vessels and then migrate to extravascular sites, with lung metastases developing more rapidly than hepatic metastases.

Supporting Evidence

  • Walker 256 tumour cells were found to adhere to the endothelium of pulmonary arterioles shortly after injection.
  • Circulating malignant cells were detected in the blood at specific time intervals after injection.
  • Histological examination showed that lung metastases developed more rapidly than hepatic metastases.

Takeaway

When cancer cells are injected into rats, they stick to the blood vessels in the lungs at first, then spread to other parts of the body, especially the lungs.

Methodology

The study involved injecting Walker 256 tumour cells into rats and examining their fate through blood samples and histological analysis of organs over time.

Limitations

The study faced technical difficulties in isolating small numbers of malignant cells from blood.

Participant Demographics

Rats were used in the experiments, specifically twenty anaesthetised rats of the same age and weight for some experiments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication